Literature DB >> 20170978

A bibliometric analysis of scientific production in mesothelioma research.

Donatella Ugolini1, Monica Neri, Cristina Casilli, Marcello Ceppi, Pier Aldo Canessa, Giovanni Paolo Ivaldi, Michela Paganuzzi, Stefano Bonassi.   

Abstract

This study aims at comparing scientific production in malignant mesothelioma (MM) among countries and evaluating publication trends and impact factor (IF). The PubMed database was searched with a strategy combining keywords listed in the Medical Subject Headings and free-text search. Publications numbers and IF were evaluated both as absolute values and after standardization by population and gross domestic product (GDP). 5240 citations were retrieved from the biennium 1951-1952 (n = 22) to 2005-2006 (n = 535). The 177% increase of MM publications from 1987 to 2006 exceeded by large the corresponding value of total cancer literature (123.5%). In these two decades, 2559 articles with IF were published: 46.4% came from the European Union (EU) (the UK, Italy and France ranking at the top), and 36.2% from the US. The highest mean IF was reported for the US (3.346), followed by Australia (3.318), and EU (2.415, with the UK, Belgium and the Netherlands first). Finland, Sweden and Australia had the best ratio between IF (sum) and resident population or GDP. The number of publications correlated with GDP (p = 0.001) and national MM mortality rates (p = 0.002). An association was found between a country commitment to MM research and the burden of disease (p = 0.04). Asbestos, survival, prognosis, occupational exposure, differential diagnosis, and immunohistochemistry were the most commonly used keywords. This report represents the first effort to explore the geographical and temporal distribution of MM research and its determinants. This is an essential step in understanding science priorities and developing disease control policies.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20170978     DOI: 10.1016/j.lungcan.2010.01.013

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  7 in total

1.  Scientific production in cancer rehabilitation grows higher: a bibliometric analysis.

Authors:  Donatella Ugolini; Monica Neri; Alfredo Cesario; Stefano Bonassi; Daniele Milazzo; Luca Bennati; Luisa Maria Lapenna; Patrizio Pasqualetti
Journal:  Support Care Cancer       Date:  2011-09-01       Impact factor: 3.603

2.  Temporal trend, geographic distribution, and publication quality in asbestos research.

Authors:  Donatella Ugolini; Stefano Bonassi; Alfonso Cristaudo; Giacomo Leoncini; Giovanni Battista Ratto; Monica Neri
Journal:  Environ Sci Pollut Res Int       Date:  2014-12-06       Impact factor: 4.223

3.  A bibliometric analysis of the 100 most influential papers on COPD.

Authors:  Wenchao Gu; Yaping Yuan; Hua Yang; Guangsheng Qi; Xiaoyan Jin; Jin Yan
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-03-25

4.  Trends and topics in eye disease research in PubMed from 2010 to 2014.

Authors:  Christophe Boudry; Eric Denion; Bruno Mortemousque; Fréderic Mouriaux
Journal:  PeerJ       Date:  2016-01-07       Impact factor: 2.984

5.  Web 2.0 applications in medicine: trends and topics in the literature.

Authors:  Christophe Boudry
Journal:  Med 2 0       Date:  2015-04-01

6.  Cisplatin for small cell lung cancer: Associated publications in Science Citation Index Expanded.

Authors:  Yuh-Shan Ho; Kensuke Nakazawa; Shinya Sato; Tomohiro Tamura; Koichi Kurishima; Hiroaki Satoh
Journal:  Oncol Lett       Date:  2012-11-15       Impact factor: 2.967

7.  Bibliometric analysis of gaps in research on asbestos-related diseases: declining emphasis on public health over 26 years.

Authors:  Ro-Ting Lin; Matthew John Soeberg; Lung-Chang Chien; Scott Fisher; Jukka Takala; Richard Lemen; Tim Driscoll; Ken Takahashi
Journal:  BMJ Open       Date:  2018-07-25       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.